← Leaderboards
Lorenz P. Studer
Sloan-Kettering Inst Can Research
$24,153,805
Attributed
$33,503,185
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,503,185 · 19
By mechanism
R01$22,321,640 · 10
UM1$7,316,442 · 1
R21$2,512,830 · 6
RC1$999,213 · 1
U24$353,060 · 1
Top collaborators
- Doron Betel11 shared
- Steven S Gross5 shared
- Giovanni Manfredi5 shared
- Danwei Huangfu4 shared
- Stewart A Anderson2 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Danwei Huangfu$13,557,080
- Nermin Sumru Bayin$188,136
- Michael Kharas$18,485,709
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsCellsGeneticCell TypeCell LineInduced Pluripotent Stem CellIn VitroTechnologyPhenotypeProtocols DocumentationDisease ModelBaseIn VivoAffectEmbryoHuman Pluripotent Stem CellBrainTransplantationInsightHuman DiseaseDopaminergic NeuronParkinson DiseaseMolecularDerivation Procedure
Grant awards (57)
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes$1,781,395
UM1 · FY2025 · HG
Novel strategies for induction of aging in human PSC-derived lineages for modeling Alzheimer's Disease$859,466
R01 · FY2025 · AG · contact PI
Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals$706,519
R01 · FY2025 · MH · contact PI
Cell Intrinsic and Extrinsic Factors Driving Maturation in Human PSC-derived Neurons$655,327
R01 · FY2025 · NS · contact PI
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons$635,925
R01 · FY2025 · NS · contact PI
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes$1,775,939
UM1 · FY2024 · HG
Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals$724,048
R01 · FY2024 · MH · contact PI
Cell Intrinsic and Extrinsic Factors Driving Maturation in Human PSC-derived Neurons$635,667
R01 · FY2024 · NS · contact PI
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons$617,673
R01 · FY2024 · NS · contact PI
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes$1,816,637
UM1 · FY2023 · HG
Cell Intrinsic and Extrinsic Factors Driving Maturation in Human PSC-derived Neurons$655,327
R01 · FY2023 · NS · contact PI
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons$636,922
R01 · FY2023 · NS · contact PI
Molecular and cellular pathways driving competency for human vagal neural crest specification$486,750
R21 · FY2023 · HD · contact PI
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes$1,942,471
UM1 · FY2022 · HG
Directing fate, subtype identity and survival in human pluripotent-derived midbrain dopamine neurons$637,063
R01 · FY2022 · NS · contact PI
Directing fate, subtype identity and survival in human pluripotent-derived midbrain dopamine neurons$675,698
R01 · FY2021 · NS · contact PI
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$505,452
R01 · FY2021 · AG · contact PI
Programming age in iPS models of Alzheimer's disease$449,000
R01 · FY2021 · AG · contact PI
MODELING ENTERIC NERVOUS SYSTEM DEVELOPMENT AND HIRSCHSPRUNG'S DISASE IN HUMAN PLURIPOTENT STEM CELLS$598,059
R01 · FY2020 · NS · contact PI
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$568,510
R01 · FY2020 · AG · contact PI
Manipulating autophagy in human neurons to determine subtype-specific neurodegenerative disease phenotypes$493,900
R21 · FY2020 · NS · contact PI
Identification of HSE-susceptibility genes using a whole genome CRISPR screen in defined human cortical neurons$486,750
R21 · FY2020 · NS · contact PI
Programming age in iPS models of Alzheimer's disease$449,000
R01 · FY2020 · AG · contact PI
MODELING ENTERIC NERVOUS SYSTEM DEVELOPMENT AND HIRSCHSPRUNG'S DISASE IN HUMAN PLURIPOTENT STEM CELLS$594,410
R01 · FY2019 · NS · contact PI
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$568,510
R01 · FY2019 · AG · contact PI
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$530,987
R01 · FY2019 · NS
Programming age in iPS models of Alzheimer's disease$449,000
R01 · FY2019 · AG · contact PI
MODELING ENTERIC NERVOUS SYSTEM DEVELOPMENT AND HIRSCHSPRUNG'S DISASE IN HUMAN PLURIPOTENT STEM CELLS$573,999
R01 · FY2018 · NS · contact PI
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$552,795
R01 · FY2018 · AG · contact PI
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$530,987
R01 · FY2018 · NS
Programming age in iPS models of Alzheimer's disease$432,000
R01 · FY2018 · AG · contact PI
MODELING ENTERIC NERVOUS SYSTEM DEVELOPMENT AND HIRSCHSPRUNG'S DISASE IN HUMAN PLURIPOTENT STEM CELLS$570,654
R01 · FY2017 · NS · contact PI
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$562,011
R01 · FY2017 · AG · contact PI
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$530,987
R01 · FY2017 · NS
Programming age in iPS models of Alzheimer's disease$432,000
R01 · FY2017 · AG · contact PI
MODELING ENTERIC NERVOUS SYSTEM DEVELOPMENT AND HIRSCHSPRUNG'S DISASE IN HUMAN PLURIPOTENT STEM CELLS$603,073
R01 · FY2016 · NS · contact PI
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$530,987
R01 · FY2016 · NS
Metabolic profiling of sporadic ALS patients: from fibroblasts to neurons and back$548,362
R01 · FY2015 · NS
Tools towards the rapid derivation of glial cells from human pluripotent cells$218,790
R21 · FY2014 · NS · contact PI
Tools towards the rapid derivation of glial cells from human pluripotent cells$265,200
R21 · FY2013 · NS · contact PI
differentiation, Genetic Repair and Reporter$168,924
U24 · FY2013 · NS · contact PI
differentiation, Genetic Repair and Reporter$184,136
U24 · FY2012 · NS · contact PI
Defining fate potential in human ESC derived neural stem cells$519,937
R01 · FY2010 · NS · contact PI
Derivation of cerebral cortical GABAergic interneurons from human iPS cells$499,211
RC1 · FY2010 · MH
Human embryonic stem cell derived midbrain dopamine neurons$395,444
R01 · FY2010 · NS · contact PI
Defining fate potential in human ESC derived neural stem cells$514,249
R01 · FY2009 · NS · contact PI
Derivation of cerebral cortical GABAergic interneurons from human iPS cells$500,002
RC1 · FY2009 · MH
Human embryonic stem cell derived midbrain dopamine neurons$399,438
R01 · FY2009 · NS · contact PI
Human embryonic stem cell derived midbrain dopamine neurons$399,438
R01 · FY2008 · NS · contact PI
Human embryonic stem cell derived midbrain dopamine neurons$399,438
R01 · FY2007 · NS · contact PI
Transcriptional Control of Mammalian Brain Development$437,931
R01 · FY2005 · NS
HTS Screen-Neural Differentiation in Human ES Cells(RMI)$209,250
R21 · FY2005 · NS
Transcriptional Control of Mammalian Brain Development$425,178
R01 · FY2004 · NS
Transcriptional Control of Mammalian Brain Development$412,791
R01 · FY2003 · NS
Therapeutic Cloning in Parkinsonian Mice$188,219
R21 · FY2003 · NS
Transcriptional Control of Mammalian Brain Development$397,378
R01 · FY2002 · NS
Therapeutic Cloning in Parkinsonian Mice$163,971
R21 · FY2002 · NS